Corpus ID: 13926853

Studies on Drug Interactions between CYP 3 A 4 Inhibitors and Glucocorticoids by

@inproceedings{Varis2000StudiesOD,
  title={Studies on Drug Interactions between CYP 3 A 4 Inhibitors and Glucocorticoids by},
  author={T. Varis},
  year={2000}
}
............................................................................................................................8 INTRODUCTION ...................................................................................................................9 REVIEW OF THE LITERATURE......................................................................................10 1. Drug metabolism.............................................................................................................10… Expand
ethesis.helsinki.fi

References

SHOWING 1-10 OF 197 REFERENCES
The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
  • 6
Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
  • 97
Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
  • 222
Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
  • 65
Effects of the Antifungal Agents on Oxidative Drug Metabolism
  • 469
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
  • 280
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.
  • 326
Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole.
  • 71
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
  • 757
  • Highly Influential
  • PDF
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
  • 154
...
1
2
3
4
5
...